Last reviewed · How we verify
Besifloxacin Ophthalmic — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Besifloxacin Ophthalmic (Besifloxacin Ophthalmic) — Instituto de Oftalmología Fundación Conde de Valenciana.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Besifloxacin Ophthalmic TARGET | Besifloxacin Ophthalmic | Instituto de Oftalmología Fundación Conde de Valenciana | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Besifloxacin Ophthalmic CI watch — RSS
- Besifloxacin Ophthalmic CI watch — Atom
- Besifloxacin Ophthalmic CI watch — JSON
- Besifloxacin Ophthalmic alone — RSS
Cite this brief
Drug Landscape (2026). Besifloxacin Ophthalmic — Competitive Intelligence Brief. https://druglandscape.com/ci/besifloxacin-ophthalmic. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab